MANKIND - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

Technical Rating: 3.6

Technical Analysis Summary

• Trend: Reversing from highs, showing short-term weakness
• Moving Averages: Price (₹2,379) is below DMA 50 (₹2,486) and DMA 200 (₹2,474), indicating bearish pressure
• RSI (45.6): Neutral zone, but leaning toward weakness
• MACD (-21.9): Bearish crossover, confirming downward momentum
• Bollinger Bands: Price near lower band, suggesting oversold conditions and possible support
• Volume: Slightly above average, indicating active selling

Entry & Exit Zones

• Support: ₹2,300 – ₹2,350 (recent base zone)
• Resistance: ₹2,475 – ₹2,500 (DMA 200 and prior swing highs)
• Optimal Entry: ₹2,340 – ₹2,360 if RSI stabilizes and MACD flattens
• Exit Zone: ₹2,475 – ₹2,500 if price struggles near moving averages

Positive

• Strong quarterly PAT of ₹413 Cr.
• EPS of ₹45.1 and ROCE of 15.0%
• Positive DII sentiment (+0.41%)
• Price up 28.1% over 52 weeks

Limitation

• MACD and RSI indicate bearish momentum
• Price trading below key moving averages
• High P/E of 54.3 vs industry average of 33.1
• PEG ratio of 6.45 suggests overvaluation

Company Negative News

• Quarterly profit variation of -13.4% raises earnings consistency concerns

Company Positive News

• Strong brand presence and expanding product portfolio in domestic pharma market
• Improving institutional interest from domestic investors

Industry

• MANKIND operates in the pharmaceuticals sector
• Peers include Cipla, Sun Pharma, and Dr. Reddy’s

Conclusion

MANKIND is currently reversing from its highs with bearish technical indicators and declining momentum. While fundamentals remain solid, valuation concerns and short-term weakness suggest caution. Traders may consider entry near ₹2,340 with targets around ₹2,500, watching for MACD and RSI recovery.